Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICIDâ¢ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associat